Upgrade to SI Premium - Free Trial

Novartis (NVS)

159.99 -3.10 (1.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/27/26)
- M&A (3/31/20 *Est)

Latest Headlines

Form 6-K NOVARTIS AG For: Sep 04 September 4, 2026 5:22 PM - SEC Filing Novartis pelacarsen trial fails to meet primary endpoint September 4, 2026 4:52 PM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF150 at BofA Securities September 4, 2026 6:06 AM - StreetInsider Premarket movers: GoPro soars 80% as Sono Group soars on Sports One deal September 1, 2026 6:38 AM - StreetInsider Form 6-K NOVARTIS AG For: Sep 01 September 1, 2026 6:21 AM - SEC Filing Novartis MS drug remibrutinib meets Phase III trial goals September 1, 2026 6:04 AM - StreetInsider FDA approves Novartis Pluvicto for earlier-stage prostate cancer July 31, 2026 4:31 PM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF120 at Berenberg July 28, 2026 4:58 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF135 at CLSA July 23, 2026 7:34 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF142 at Citi July 22, 2026 4:28 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF125 at Barclays July 22, 2026 4:20 AM - StreetInsider JPMorgan Reiterates Overweight Rating on Novartis (NOVN:SW) (NVS) July 22, 2026 2:48 AM - StreetInsider Novartis CEO says will stay with drugmaker for next growth phase July 21, 2026 7:29 AM - StreetInsider Form 6-K NOVARTIS AG For: Jun 30 July 21, 2026 6:26 AM - SEC Filing Novartis (NVS) Tops Q2 EPS by 23c; offers outlook July 21, 2026 3:25 AM - StreetInsider Novartis wins EU approval for SMA gene therapy in older patients July 2, 2026 6:07 AM - StreetInsider Increasing unusual put volume: STRC EWA HTZ EIX NVS SITM WEN STWD VSH PENG ZIM July 1, 2026 10:39 AM - StreetInsider Barclays Reiterates Equalweight Rating on Novartis (NOVN:SW) (NVS) June 30, 2026 4:24 AM - StreetInsider Novartis (NOVN:SW) (NVS) PT Raised to CHF140 at Deutsche Bank June 25, 2026 6:36 AM - StreetInsider The Quest to Repair What Multiple Sclerosis Takes Away June 24, 2026 8:30 AM - StreetInsider Antares Therapeutics and Novartis team up on cancer drug discovery June 24, 2026 8:15 AM - StreetInsider German government to drop variable drug discounting plans - Reuters June 15, 2026 6:08 AM - StreetInsider Novartis drug shows efficacy in chronic urticaria trial June 12, 2026 5:49 AM - StreetInsider Form 6-K NOVARTIS AG For: Jun 11 June 11, 2026 7:58 AM - SEC Filing Novartis reports positive biomarker results for experimental FSHD treatment June 11, 2026 3:18 AM - StreetInsider Full Article List